Ashcraft & Gerel LLP The Victims' Rights Law Firm Washington, D.C. Maryland (Baltimore Landover Rockville) Virginia

Avandia (Rosiglitazone) - Study Finds Increased Rate of Heart Attacks and Death From Heart Related Vascular (Cardiovascular) Disease, Such as Congestive Heart Failure or CHF - FDA Issues Safety Alert

Avandia (Rosiglitazone) - Study Finds Increased Rate of Heart Attacks and Death From Heart Related Vascular (Cardiovascular) Disease, Such as Congestive Heart Failure or CHF - FDA Issues Safety Alert

[Introduction: If you or a loved one has experienced a heart attack or has died of heart related (cardiovascular) disease after using the diabetes medication Avandia, you may have a lawsuit that should be pursued. Although our Avandia lawyers are located in Maryland (MD), Virginia (VA) and Washington, D.C. (DC), our drug litigation is national in scope, and our Avandia lawyers are prepared to file lawsuits and litigate Avandia cases around the country. Therefore, regardless of what state you are from, please fill out our inquiry form on this web site or email us so that Ashcraft & Gerel, LLP can have an Avandia lawyer contact you to discuss your claim and the potential of a lawsuit.] 

Avandia (rosiglitazone) is a widely prescribed medication to treat Type-2 Diabetes Mellitus, a condition which also known as Adult-Onset Diabetes. Manufactured by GlaxoSmithKline, Avandia (rosiglitazone) was approved for the treatment of Type-2 Diabetes in the U.S. in 1999. Avandia is also contained in combination with other drugs in medications called Avandryl and Avandamet. To date, more than six (6) million people worldwide have taken the drug, and Avandia generates approximately $3.2 billion in annual sales for its manufacturer. However, on May 21, 2007, the United States Food & Drug Administration ("FDA") issued a Safety Alert regarding Avandia. There has not yet been a recall or a black box warning required by the FDA for Avandia, but in the event this product is recalled this site will be updated.

The FDA Safety Alert warns that patients who are taking Avandia (rosiglitazone) - especially those who are known to have underlying heart disease or who are at high risk of heart attack (myocardial infarction) -  should speak to their physicians about their continued use of Avanidia.

The FDA's Safety Alert follows a study released on the same day, which will appear in the June 14, 2007 issue of the New England Journal of Medicine. This type of study, known as a 'meta-analysis', evaluated forty-two (42) separate studies comparing patients using Avandia (rosiglitazone) to patients who were not using Avandia. This study concludes that patients taking Avanida (rosiglitazone) face a 43% increased risk of heart attack, and a 64% increased risk of dying from heart related ( cardiovascular) disease, such as congestive heart failure or CHF. Cardiovascular disease refers to the class of diseases that affect the heart and/or blood vessels, which includes but is not limited to heart attacks (myocardial infarction) and congestive heart failure. As indicated above, there has not yet been a recall, nor has the FDA yet required that the manufacturer issue a black box warning label for Avandia, but in the event Avandia is subjected to a recall, this site will be updated.

If you or a loved one has experienced a heart attack (myocardial infarction) or complications and/or death due to heart related (cardiovascular) disease, such as congestive heart failure, please visit your healthcare provider immediately. If a visit to your healthcare provider is warranted, you also owe it to yourself to speak to an experienced pharmaceutical attorney to see if you have a case and to discuss the possibility of bringing a lawsuit to recover for your own  damages and injuries or a wrongful death lawsuit to recover for the loss of a loved one. The attorney will be able to ascertain if you have an Advandia claim for which a lawsuit can be pursued and whether the case and lawsuit can be brought to a successful settlement, verdict, award or other recovery. The experienced lawyer will also be able to advise you on any deadlines for bringing your legal claim for damages. Please contact the law firm of Ashcraft and Gerel, LLP to discuss your lawsuit with an experienced drug or pharmaceutical lawyer in our Drug Litigation Department.

The lawyers at Ashcraft and Gerel, LLP have been leaders in pursuing lawsuits involving unsafe drugs, recalls of medical products, implants, and infusions for over 50 years. Our attorneys have successfully brought about verdicts, settlements, awards or other recoveries in lawsuits on behalf of clients who have been injured by Zyprexa, Fen-Phen, Rezulin, Propulsid, Phenylpropanolamine (PPA), Baycol, breast implants and AIDS tainted blood. Although some of these claims and lawsuits resulted in class action settlements, class actions are not the only way these cases are handled. The courts have devised methods to deal with mass torts so that each lawsuit can benefit from information and evidence gathered in other lawsuits nationwide and yet be handled on an individual basis.

We have a toll free (no cost) telephone number to reach an attorney to answer your questions with regard to your specific case. That number is 1-866-675-5200. Please ask to speak to Nan Parfitt, our chief Drug & Medical Product Liability paralegal , and she will place you in touch with one of our drug litigation lawyers. If you would prefer, please feel free to e-mail us or complete the help inquiry form on this web site. Please be sure to include your name, address, telephone number (if you wish to be called), email address and the exact nature of your question, so that our lawyer can provide you with the specific information you seek.